The European Pediatric Pulmonary Vascular Disease Network is a registered, non-profit
organization that strives to define and develop effective, innovative diagnostic methods and …

For years, guanylate cyclase seemed to be homogenic and tissue nonspecific enzyme;
however, in the last few years, in light of preclinical and clinical trials, it became an …

Pediatric pulmonary hypertension (PPH) is a multifactorial disease with diverse etiologies
and presenting features. Pulmonary hypertension (PH), defined as elevated pulmonary …

BACKGROUND The European Pediatric Pulmonary Vascular Disease Network (EPPVDN)
investigated the safety and efficacy of add-on selexipag, an oral prostacyclin receptor …

The European Pediatric Pulmonary Vascular Disease Network is a registered, non-profit
organization that strives to define and develop effective, innovative diagnostic methods and …

Objective While pulmonary arterial hypertension (PAH) is rare in infants and children, it
results in substantial morbidity and mortality. In recent years, prognosis has improved …

Objectives To assess whether better baseline pulmonary hemodynamics or positive acute
vasoreactivity testing (AVT) during cardiac catheterization are associated with improved …

Background We investigated whether RV function recovers in children with pulmonary
arterial hypertension (PAH) and RV failure undergoing lung transplantation (LuTx). Methods …

Abstract Background Circular RNAs (circRNAs) have been found to be involved in the
development of pulmonary arterial hypertension (PAH). However, their diagnostic value in …

Pulmonary arterial hypertension (PAH) is a rare and devastating disease of the pulmonary
vasculature with a high morbidity and mortality rate in infants and children. Currently …